<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02318134</url>
  </required_header>
  <id_info>
    <org_study_id>Nanchanguniversity</org_study_id>
    <nct_id>NCT02318134</nct_id>
  </id_info>
  <brief_title>Fecal Microbiota Transplantation for Pancreatitis</brief_title>
  <acronym>FMTP</acronym>
  <official_title>Fecal Microbiota Transplantation in SAP（Severe Acute Pancreatitis）Patients With Intestinal Barrier Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Nanchang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital of Nanchang University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The intestinal microbiota plays a pivotal role in the maintenance of intestinal homeostasis
      and protecting the gut against pathogens by competing for nutrients, creating the intestinal
      biological barrier and modulating the host immune system.After the onset of acute
      pancreatitis,the intestinal hypoperfusion and the release of inflammatory mediators result in
      intestinal barrier dysfunction and intestinal bacteria dysbiosis.This leads to Bacterial and
      endotoxin translocation, which may cause infectious complications which are major causes of
      death in SAP patients.Recently,FMT was shown its efficacy in the treatment of
      gastrointestinal(GI) diseases and non-GI disorders associated with Intestinal flora
      disturbance by re-establishing the damaged Intestinal Bacteria homeostasis.However,the
      mechanism by which FMT results in cure of diseases has been poorly understood.This study aims
      to investigate the therapeutic potential of FMT for SAP patients with intestinal barrier
      dysfunction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators aims to restore the intestinal bacteria homeostasis through FMT by retention
      enema with fresh bacteria,thus stabilizing intestinal barrier dysfunction,minimizing
      bacterial translocation and preventing infectious complications.The investigators will
      further examine the effect of FMT on inflammatory markers，the predictors of Intestinal
      barrier injury and the incidence of infectious complications.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 3, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastrointestinal Failure score</measure>
    <time_frame>everyday after intervention for 7 days or 14 days</time_frame>
    <description>gastrointestinal failure score is a comprehensive score for assessing gastrointestinal function. Gastrointestinal dysfunction score gets o point meaning enteral nutrition&gt; 50% of the required amount and no intra-abdominal hypertension.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of infectious complications</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>The incidence of infectious complications，such as pancreatic pseudocyst、walled-off necrosis、infected necrosis、Bacteraemia、Infected ascites.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of organ failure</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>The incidence of organ failure,such as acute respiratory failure,acute renal failure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>interventions or surgery</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>patients needs extra interventions or surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Intensive care time and hospital stay</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>patients' Length of Intensive care time and hospital stay due to the disease</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>patients who die due to the diseases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the number of defecation</measure>
    <time_frame>up to 12 weeks</time_frame>
    <description>the time to restore spontaneous defecation, after the daily number of defecation and defecation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diamine oxidase（DAO）</measure>
    <time_frame>1day before intervention，7days and 14days after intervention</time_frame>
    <description>Plasma Diamine oxidase（DAO）level as a predictor in the diagnosis of Intestinal mucosal barrier injury</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>D-lactate</measure>
    <time_frame>1day before intervention，7days and 14days after intervention</time_frame>
    <description>Plasma D-lactate level as a predictor in the diagnosis of Intestinal mucosal</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Acute Pancreatitis</condition>
  <condition>Intestinal Bacteria Flora Disturbance</condition>
  <condition>Intestinal Dysfunction</condition>
  <condition>Fecal Microbiota Transplantation</condition>
  <arm_group>
    <arm_group_label>Fecal Microbiota Transplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>FMT by retention enema with fresh bacteria from healthy donor，At the same time give patients the traditional treatment of SAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>The traditional treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The traditional treatment of SAP according to the associated guidelines</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fecal Microbiota Transplantation</intervention_name>
    <description>FMT by retention enema with fresh bacteria from healthy donor</description>
    <arm_group_label>Fecal Microbiota Transplantation</arm_group_label>
    <other_name>Fecal Microbiota Therapy</other_name>
    <other_name>Fecal Transplantation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>The traditional treatment</intervention_name>
    <description>the traditional treatments according to associated guidelines</description>
    <arm_group_label>Fecal Microbiota Transplantation</arm_group_label>
    <arm_group_label>The traditional treatment</arm_group_label>
    <other_name>Conventional drugs according to the guideline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diagnosis of acute pancreatitis from the First Affiliated Hospital of Nanchang
             University according to the Classification of acute pancreatitis-2012: revision of the
             Atlanta classification and definitions by international consensus

          2. Onset of pancreatitis within &lt;=2 weeks

          3. Gastrointestinal failure score (GIF score) &gt;= 2 points. That is, food intolerance (due
             to high gastric retention, vomiting, flatulence or severe diarrhea) or intraperitoneal
             hypertension (≥ 12mmHg);

        Exclusion Criteria:

          1. SAP complicated by Gastrointestinal bleeding or Intestinal fistula

          2. Pregnancy and lactation women

          3. Not signed the informed consent

          4. Diabetes and autoimmune diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nonghua Lv, MD</last_name>
    <role>Study Chair</role>
    <affiliation>the Frist Affiliated Hospital of Nanchang University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yin Zhu, MD</last_name>
    <phone>13970841464</phone>
    <email>zhuyin27@sina.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lingyu Luo, MD</last_name>
    <phone>15270855639</phone>
    <email>15270855639@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>the First Affiliated Hospital of Nanchang University</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <zip>330006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nonghua Lv, MD</last_name>
      <phone>13707086809</phone>
      <email>lunonghua@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Kunhe Zhang, MD</last_name>
      <phone>13007202818</phone>
      <email>393467260@qq.com</email>
    </contact_backup>
    <investigator>
      <last_name>Nonghua Lv, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.cdyfy.com/</url>
    <description>the First Affiliated Hospital of Nanchang University</description>
  </link>
  <reference>
    <citation>Liu H, Li W, Wang X, Li J, Yu W. Early gut mucosal dysfunction in patients with acute pancreatitis. Pancreas. 2008 Mar;36(2):192-6. doi: 10.1097/MPA.0b013e31815a399f.</citation>
    <PMID>18376312</PMID>
  </reference>
  <reference>
    <citation>Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS; Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013 Jan;62(1):102-11. doi: 10.1136/gutjnl-2012-302779. Epub 2012 Oct 25.</citation>
    <PMID>23100216</PMID>
  </reference>
  <reference>
    <citation>Reintam Blaser A, Malbrain ML, Starkopf J, Fruhwald S, Jakob SM, De Waele J, Braun JP, Poeze M, Spies C. Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems. Intensive Care Med. 2012 Mar;38(3):384-94. doi: 10.1007/s00134-011-2459-y. Epub 2012 Feb 7.</citation>
    <PMID>22310869</PMID>
  </reference>
  <reference>
    <citation>Landy J, Al-Hassi HO, McLaughlin SD, Walker AW, Ciclitira PJ, Nicholls RJ, Clark SK, Hart AL. Review article: faecal transplantation therapy for gastrointestinal disease. Aliment Pharmacol Ther. 2011 Aug;34(4):409-15. doi: 10.1111/j.1365-2036.2011.04737.x. Epub 2011 Jun 20. Review.</citation>
    <PMID>21682755</PMID>
  </reference>
  <reference>
    <citation>Smits LP, Bouter KE, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology. 2013 Nov;145(5):946-53. doi: 10.1053/j.gastro.2013.08.058. Epub 2013 Sep 7. Review.</citation>
    <PMID>24018052</PMID>
  </reference>
  <reference>
    <citation>Brandt LJ, Aroniadis OC. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointest Endosc. 2013 Aug;78(2):240-9. doi: 10.1016/j.gie.2013.03.1329. Epub 2013 May 2. Review.</citation>
    <PMID>23642791</PMID>
  </reference>
  <reference>
    <citation>Seekatz AM, Aas J, Gessert CE, Rubin TA, Saman DM, Bakken JS, Young VB. Recovery of the gut microbiome following fecal microbiota transplantation. MBio. 2014 Jun 17;5(3):e00893-14. doi: 10.1128/mBio.00893-14.</citation>
    <PMID>24939885</PMID>
  </reference>
  <reference>
    <citation>Singh R, Nieuwdorp M, ten Berge IJ, Bemelman FJ, Geerlings SE. The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection. Clin Microbiol Infect. 2014 Nov;20(11):1119-25. doi: 10.1111/1469-0691.12799. Epub 2014 Nov 7. Review.</citation>
    <PMID>25274035</PMID>
  </reference>
  <reference>
    <citation>Allegretti JR, Hamilton MJ. Restoring the gut microbiome for the treatment of inflammatory bowel diseases. World J Gastroenterol. 2014 Apr 7;20(13):3468-74. doi: 10.3748/wjg.v20.i13.3468. Review.</citation>
    <PMID>24707129</PMID>
  </reference>
  <reference>
    <citation>Shankar V, Hamilton MJ, Khoruts A, Kilburn A, Unno T, Paliy O, Sadowsky MJ. Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following fecal microbiota transplantation. Microbiome. 2014 Apr 21;2:13. doi: 10.1186/2049-2618-2-13. eCollection 2014.</citation>
    <PMID>24855561</PMID>
  </reference>
  <reference>
    <citation>Cui LH, Wang XH, Peng LH, Yu L, Yang YS. [The effects of early enteral nutrition with addition of probiotics on the prognosis of patients suffering from severe acute pancreatitis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013 Apr;25(4):224-8. doi: 10.3760/cma.j.issn.2095-4352.2013.04.011. Chinese.</citation>
    <PMID>23660099</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2014</study_first_submitted>
  <study_first_submitted_qc>December 16, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2014</study_first_posted>
  <last_update_submitted>November 15, 2017</last_update_submitted>
  <last_update_submitted_qc>November 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Affiliated Hospital of Nanchang University</investigator_affiliation>
    <investigator_full_name>Lingyu Luo</investigator_full_name>
    <investigator_title>Physician-in-charge</investigator_title>
  </responsible_party>
  <keyword>Severe acute pancreatitis</keyword>
  <keyword>Fecal Microbiota Transplantation</keyword>
  <keyword>Intestinal barrier dysfunction</keyword>
  <keyword>Intestinal flora</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Dysbiosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

